相关实验视频
Updated: Jun 23, 2025
07:45
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
53.1K
通过p38-MAPK通路进行急性 катехоламин输液后,普罗普拉诺洛尔可缓解心脏损伤
Tzu-Hao Liu1, Rebecca Jen-Ling Hsieh2, Hsin-Hung Chen2
1Department of Pediatrics, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan.
Journal of cardiovascular pharmacology
|June 26, 2024
概括
严重的超大胆胺激素性疾病会导致心力衰竭. 通过调节p-38 MAPK通路,兰醇 (1 mg/kg) 玻尿酸治疗显著减少了大鼠的心脏损伤和纤维化.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 超大胆氨酸性疾病可能导致严重的心力衰竭和心脏纤维化.
- 之前关于白阻塞在 катехоламинергия状态中的研究在现实模型中存在局限性.
- 在超上腺状态下β阻塞的确切益处需要进一步研究.
研究的目的:
- 为了研究由甲醇胺诱导的心力衰竭的小鼠模型中的急性心脏变化.
- 为了评估propranolol治疗在缓解这些心脏变化的有效性.
- 阐明涉及catecholamine引起的心脏损伤的分子途径和propranolol的影响.
主要方法:
- 雄性斯普拉格-道利大鼠接受了长达6小时的上腺素和上腺素输注.
- 一组在第1小时接受了额外的propranolol (1 mg/kg) 玻尿酸.
- 6小时后使用免疫组织化学分析了心脏组织.
主要成果:
- 单独注入catecholamine就会增加活性氧化物种和益纤维化蛋白,降低酸化p-38.
- 普罗巴诺洛尔治疗使酸化p-38水平正常化,并降低了apoptotic和profibrotic通路的调节.
- 包括MMP-9,α-SMA和FGF23在内的关键的益菌媒介受到了影响.
结论:
- 甲基胺诱导的心力衰竭涉及p-38 MAPK通路,益纤维化和亡.
- 单次布拉诺醇大剂 (1 mg/kg) 有效地减轻了由甲醇胺诱导的急性心脏损伤.
- 普罗兰醇通过向p-38 MAPK通路,纤维化和亡来缓解甲基醇的过剩.
相关概念视频
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
685
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
685
01:16Antianginal Drugs: Nitrates and β-Blockers
571
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
571
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:28Antihypertensive Drugs: Types of β-Blockers
635
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
635
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:17Antihypertensive Drugs: Action of β1 Blockers
416
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
416